Genovis AB, a leading provider of innovative enzyme technologies, today announced it has received an order with a total value of approximately EUR 1 million (SEK 11 million) from a global pharmaceutical company. The order includes material and related services connected to one of Genovis’ proprietary antibody conjugation technology platforms. Genovis’ technology platform will be [...]

BOSTON -- 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that the United States Marine Corps CBRNE Installation and Protection Program purchased 17 of the company’s XplorIR devices for the chemical identification and quantification of hazardous gases and vapors. The program’s mission is to support federal firefighters, military police, post offices [...]

WALTHAM, Mass. --  Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced plans to further increase the impact of Thermo Fisher’s proven growth strategy through the use of artificial intelligence (AI) with OpenAI. This collaboration will help to improve the speed and success of drug development, enabling customers to get medicines [...]

ROLLE, Switzerland and TOKYO -- A.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company pioneering data-driven medicine, today announced at ESMO a strategic agreement to bring cutting-edge liquid biopsy genomic testing to the Japanese population. The companies will also partner to commercialize a liquid biopsy companion diagnostic aimed at advancing personalized and [...]

Tod White Promoted to President; Justin McAnear Appointed Chief Financial Officer FREMONT, Calif. -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced key additions to its executive leadership team. These appointments reflect the company's continued momentum and its commitment to scaling innovation, operational excellence, and strategic growth. The [...]

Merck KGaA, Darmstadt, Germany, is well-positioned for the next wave of growth following strategic portfolio streamlining and targeted investments. Strong position in attractive growth markets due to focused high-tech portfolio and targeted investments Process Solutions, the new Rare Diseases portfolio and Semiconductor Solutions to drive up to 80% of future growth Company targets mid-term annual [...]

Waltham, MA -- We are proud to announce that Advanced Instruments and Nova Biomedical are now officially doing business under a single, unified brand. This is a transformative moment in our journey to deliver greater value to customers across the biopharmaceutical and clinical markets. Starting today we will be also unveiling a refreshed brand identity [...]

The Mystra platform, developed over 10 years, offers biopharma partners proven analytical power to turn months of R&D into minutes, dramatically increasing the availability of quality genetic insights and, therefore, the probability of honing in on successful drug candidates BOSTON -- Genomics, a science-led techbio company using large-scale genetic information to develop innovative precision healthcare tools [...]

Vienna, Austria — Lexogen, a leader in RNA sequencing technologies, announces the launch of the miRVEL Profiling Small RNA-Seq Library Prep Kit, designed to facilitate small RNA research. The innovative kit integrates seamlessly in the miRVEL small RNA sequencing line and helps scientists achieve reliable results faster and with less hands-on work. The miRVEL Profiling [...]

OXFORD, England -- At the American Society of Human Genetics (ASHG) 2025 industry session on 16th October, Oxford Nanopore Technologies will share its latest developments in enabling translational and clinical human genetics communities to deliver improved insights into mechanisms for disease in one integrated analysis. The team will highlight the unique capabilities of the PromethION in delivering comprehensive whole [...]